{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:52:33Z","timestamp":1784141553056,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Bladder drug delivery via catheter instillation is a widely used treatment for recurrence of superficial bladder cancer. Intravesical instillation of liposomal botulinum toxin has recently shown promise in the treatment of overactive bladder and interstitial cystitis\/bladder pain syndrome, and studies of liposomal tacrolimus instillations show promise in the treatment of hemorrhagic cystitis. Liposomes are lipid vesicles composed of phospholipid bilayers surrounding an aqueous core that can encapsulate hydrophilic and hydrophobic drug molecules to be delivered to cells via endocytosis. This review will present new developments on instillations of liposomes and liposome-encapsulated drugs into the urinary bladder for treating lower urinary tract dysfunction.<\/jats:p>","DOI":"10.3390\/toxins8030081","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T13:31:03Z","timestamp":1458307863000},"page":"81","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction"],"prefix":"10.3390","volume":"8","author":[{"given":"Joseph","family":"Janicki","sequence":"first","affiliation":[{"name":"Lipella Pharmaceuticals, Pittsburgh, PA 19019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chancellor","sequence":"additional","affiliation":[{"name":"Lipella Pharmaceuticals, Pittsburgh, PA 19019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Lipella Pharmaceuticals, Pittsburgh, PA 19019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gruber","sequence":"additional","affiliation":[{"name":"Lipella Pharmaceuticals, Pittsburgh, PA 19019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chancellor","sequence":"additional","affiliation":[{"name":"Lipella Pharmaceuticals, Pittsburgh, PA 19019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3892\/mco.2014.314","article-title":"Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review)","volume":"2","author":"Weintraub","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/iju.12085","article-title":"Intravesical drug delivery for dysfunctional bladder","volume":"20","author":"Hsu","year":"2013","journal-title":"Int. J. Urol."},{"key":"ref_3","first-page":"e181","article-title":"State of the art in intravesical therapy for lower urinary tract symptoms","volume":"12","author":"Kaufman","year":"2010","journal-title":"Rev. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.2000.278.6.F867","article-title":"Everything you wanted to know about the bladder epithelium but were afraid to ask","volume":"278","author":"Lewis","year":"2000","journal-title":"Am. J. Physiol. Renal Phisiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1600-0854.2003.00156.x","article-title":"The uroepithelium: Not just a passive barrier","volume":"5","author":"Apodaca","year":"2004","journal-title":"Traffic"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1242\/jcs.00811","article-title":"Structural basis of urothelial permeability barrier function as revealed by cryo-em studies of the 16 nm uroplakin particle","volume":"116","author":"Min","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1461-5347(99)00171-6","article-title":"Liposomes, micelles and microemulsions as new delivery systems for cytotoxic alkaloids","volume":"2","author":"Cortesi","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","article-title":"Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxin A for patients with overactive bladder: A single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0167-7799(00)89017-4","article-title":"Engineering liposomes for drug delivery: Progress and problems","volume":"13","author":"Gregoriadis","year":"1995","journal-title":"Trends Biotechnol."},{"key":"ref_11","first-page":"49","article-title":"Clinical development of liposome-based drugs: Formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_12","first-page":"F886","article-title":"Permeability properties of the intact mammalian bladder epithelium","volume":"271","author":"Negrete","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2005.05.022","article-title":"Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis","volume":"301","author":"Pavelic","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197609232951305","article-title":"The carrier potential of liposomes in biology and medicine (first of two parts)","volume":"295","author":"Gregoriadis","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rajaganapathy, B.R., Chancellor, M.B., Nirmal, J., Dang, L., and Tyagi, P. (2015). Bladder uptake of liposomes after intravesical administration occurs by endocytosis. PLoS ONE.","DOI":"10.1371\/journal.pone.0122766"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/nau.22508","article-title":"Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium","volume":"34","author":"Barrick","year":"2015","journal-title":"Neurourol. Urodyn."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s11255-014-0745-7","article-title":"Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells","volume":"46","author":"Nirmal","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s11255-014-0828-5","article-title":"Liposomal bladder instillations for IC\/BPS: An open-label clinical evaluation","volume":"46","author":"Peters","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chancellor, M.B., and Smith, C.P. (2011). Botulinum Toxin in Urology, Springer.","DOI":"10.1007\/978-3-642-03580-7"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.eururo.2014.02.046","article-title":"OnabotulinumtoxinA: How Deep Will It Go?","volume":"65","author":"Michel","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1464-410X.2010.09317.x","article-title":"Botulinum toxin for the lower urinary tract","volume":"105","author":"Chuang","year":"2010","journal-title":"BJU Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","article-title":"In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats","volume":"66","author":"Khera","year":"2005","journal-title":"Urology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","article-title":"Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats","volume":"172","author":"Chuang","year":"2004","journal-title":"J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C1013","DOI":"10.1152\/ajpcell.1994.267.4.C1013","article-title":"Mammalian urinary bladder permeability is altered by cationic proteins: Modulation by divalent cations","volume":"267","author":"Tzan","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxin A improves overactive bladder symptoms: A prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/S0041-1345(01)01994-7","article-title":"FK506-mediated T-cell apoptosis induction","volume":"33","author":"Migita","year":"2001","journal-title":"Transplant. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/nau.20981","article-title":"Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis","volume":"30","author":"Chuang","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.juro.2012.10.123","article-title":"Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure","volume":"189","author":"Nirmal","year":"2013","journal-title":"J. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.juro.2015.03.108","article-title":"Intravesical liposomal tacrolimus protects against radiation cystitis induced by 3-beam targeted bladder radiation","volume":"194","author":"Rajaganapathy","year":"2015","journal-title":"J. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s11255-015-1098-6","article-title":"Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis","volume":"47","author":"Dave","year":"2015","journal-title":"Int. Urol. Nephrol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/3\/81\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:57Z","timestamp":1760210457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/3\/81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["toxins8030081"],"URL":"https:\/\/doi.org\/10.3390\/toxins8030081","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]}}}